Research

Pilot Study of the Prospective Identification of Changes in Cognitive Function During Chemotherapy Treatment for Advanced Ovarian Cancer


 

Conflicts of interest: None to disclose.

Correspondence to: Lisa M. Hess, PhD, Indiana University School of Medicine, Department of Public Health, 714 N Senate Avenue, Indianapolis, IN 46202; telephone: (317) 274-3148; Fax (317) 274-3443


1 PubMed ID in brackets

Pages

Recommended Reading

Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapse
MDedge Hematology and Oncology
Lymphadenectomy and Cervical Cancer
MDedge Hematology and Oncology